Current Hematologic Malignancy Reports
Overview
Current Hematologic Malignancy Reports is a scientific journal, published by Current Science since 2006 in English. The journal's country of origin is United States and its primary focus areas are oncology and hematology.
Details
Details
Abbr.
Curr Hematol Malig Rep
Publisher
Current Science
Start
2006
End
Continuing
Frequency
Quarterly
p-ISSN
1558-8211
e-ISSN
1558-822X
Country
United States
Language
English
Specialties
Oncology
Hematology
Hematology
Metrics
Metrics
h-index / Ranks: 8115
44
SJR / Ranks: 3818
998
CiteScore / Ranks: 3060
6.80
JIF / Ranks: 3624
2.9
Recent Articles
21.
Tawfiq R, Abeykoon J, Kapoor P
Curr Hematol Malig Rep
. 2024 Mar;
19(3):120-137.
PMID: 38536576
Purpose Of Review: The treatment of Waldenström macroglobulinemia (WM) has evolved over the past decade. With the seminal discoveries of MYD88 and CXCR warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) mutations...
22.
Chen J, Castillo Tokumori F, Del Guzzo C, Kim J, Ruan J
Curr Hematol Malig Rep
. 2024 Mar;
19(3):93-103.
PMID: 38451372
Purpose Of Review: T-cell lymphomas (TCLs) are a group of rare subtypes of non-Hodgkin lymphoma derived from mature T-lymphocytes. Recent updates in lymphoma classification based on the cell-of-origin pathogenesis have...
23.
Bose P
Curr Hematol Malig Rep
. 2024 Mar;
19(3):111-119.
PMID: 38441783
Purpose Of Review: Summarize best practices for management of patients with early myelofibrosis (MF). Recent Findings: Myelofibrosis is a progressive myeloproliferative neoplasm (MPN) that generally produces burdensome symptoms and ultimately...
24.
Rea D, Fodil S, Lengline E, Raffoux E, Cayuela J
Curr Hematol Malig Rep
. 2024 Feb;
19(3):104-110.
PMID: 38393431
Purpose Of Review: The discovery that patients suffering from chronic myeloid leukemia who obtain deep and long-lasting molecular responses upon treatment with tyrosine kinase inhibitors may maintain their disease silent...
25.
Warsame F, Simonetto D
Curr Hematol Malig Rep
. 2024 Feb;
19(2):75-81.
PMID: 38372947
Purpose Of Review: Telomere biology disorders (TBD) encompass several illnesses caused by underlying mutations in telomere maintenance leading to premature telomere attrition and telomere dysfunction. These disorders have unique features...
26.
Coombs C
Curr Hematol Malig Rep
. 2024 Feb;
19(2):65-74.
PMID: 38337108
Purpose Of Review: The therapeutic landscape for chronic lymphocytic leukemia (CLL) has undergone a complete makeover following the introduction of highly effective targeted therapies, beginning with ibrutinib which first attained...
27.
Lin R, Dahi P, Korc-Grodzicki B, Shahrokni A, Jakubowski A, Giralt S
Curr Hematol Malig Rep
. 2024 Feb;
19(2):82-91.
PMID: 38332462
Purpose Of Review: Hematologic malignances more commonly affect older individuals and often present with advanced, higher risk disease than younger patients. Allogeneic and autologous hematopoietic cell transplantation is well-established treatment...
28.
Pennington K, Simonetto D, Taner T, Mangaonkar A
Curr Hematol Malig Rep
. 2024 Feb;
19(6):293-299.
PMID: 38315384
Purpose Of The Review: This study aimed to summarize evidence and provide consensus-based guidelines for management of transplantation in patients with telomere biology disorders (TBD). Specifically, this review focuses on...
29.
Karunakaran P, Jain N, Lad D
Curr Hematol Malig Rep
. 2024 Feb;
19(2):56-64.
PMID: 38300458
Purpose Of Review: Chronic lymphocytic leukemia was an ignored leukemia in India until a decade back, given its low prevalence and absence of novel drugs to treat it. Healthcare in...
30.
Bajwa A, Habib A, Kittai A
Curr Hematol Malig Rep
. 2024 Jan;
19(2):45-55.
PMID: 38194201
Purpose Of Review: This review presents recently published clinical trial data and ongoing investigations regarding the treatment of Richter's transformation (RT). Recent Findings: Recently, numerous approaches have been investigated for...